» Articles » PMID: 9516864

The International Neuroblastoma Risk Groups (INRG): a Preliminary Report

Citing Articles

Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review.

Jahangiri L Med Sci (Basel). 2024; 12(1).

PMID: 38249081 PMC: 10801560. DOI: 10.3390/medsci12010005.


Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets.

Yang Y, Li H, Zheng D, Li X, Liu H Aging (Albany NY). 2023; 15(22):13345-13367.

PMID: 38019470 PMC: 10713432. DOI: 10.18632/aging.205246.


Metastasis in Neuroblastoma and Its Link to Autophagy.

Jahangiri L Life (Basel). 2023; 13(3).

PMID: 36983973 PMC: 10056181. DOI: 10.3390/life13030818.


Exosomes in Neuroblastoma Biology, Diagnosis, and Treatment.

Jahangiri L, Ishola T Life (Basel). 2022; 12(11).

PMID: 36362869 PMC: 9694311. DOI: 10.3390/life12111714.


Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

Irwin M, Naranjo A, Zhang F, Cohn S, London W, Gastier-Foster J J Clin Oncol. 2021; 39(29):3229-3241.

PMID: 34319759 PMC: 8500606. DOI: 10.1200/JCO.21.00278.